Paradigm Biopharmaceuticals Ltd Investor Webinar Transcript
Thank you for standing by, and welcome to the Paradigm Biopharmaceuticals investor webinar, today. All participants are in a listen-only mode. There will be an initial slide presentation lasting approximately 40 minutes before we allow some time to get through as much Q&A as possible. (Operator Instructions) [If you are here] on behalf of Paradigm today, we have Chairman, Paul Rennie; CEO, Marco Polizzi; Chief Medical Officer, Dr. Donna Skerrett; and Director of Investor Relations, Simon White. To begin, I'll hand it over to Simon. Please go ahead.
Thanks, Matt. And a big welcome and thank you to everyone who has dialed into today's investor update. Today's webinar is an opportunity for Paradigm to introduce a new CEO, Marco Polizzi, who officially joins the company on July 1. Marco will provide some detail on his background in the industry and what excites him with the opportunity in front of us at Paradigm. We will then hear from Dr. Donna Skerrett on the progress
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |